|Articles|June 17, 2011

CoreLab Partners Showcases Technologies at 47th Annual DIA Meeting

CoreLab Partners

will showcase several new technological solutions to coincide with the upcoming DIA meeting in Chicago, Illinois to be held from June 20 - 23, 2011.

“I am pleased to announce that as a part of an on-going commitment to our sponsor partners to deliver the highest possible quality through a cost effective, technologically driven process, we are positioned to launch another series of enabling solutions in both our ImagEngine SM and WebHeart platforms”, said CoreLab Partners’ President and CEO, Dr. Mike Woehle . “Our proprietary advanced imaging application, ImagEngineSM, will perform 3D and volumetric measurements while incorporating multi-planer reconstruction tools with lesion propagation which will expand our therapeutic reach and addresses the growing needs for this type of image analysis going forward,” added Woehler.

CoreLab Partners invites you to learn more about their comprehensive suite of service capabilities and new technological solutions at booth #1035 at the 47th Annual DIA meeting in Chicago, Illinois.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related to this article

© photon_photo - © photon_photo - stock.adobe.com

October 22nd, 2026

Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology

Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.

October 22nd, 2026

Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.

October 22nd, 2026

ACT Brief: Applied Clinical Trials at 2026 SCRS Global Site Solutions Summit

In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.

© putilov_denis - © putilov_denis - stock.adobe.com

October 21st, 2026

Obesity Is More Than Weight: Practical Approaches to Managing Comorbidities in Clinical Research

Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.

October 21st, 2026

What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.

A new Syneos Health-Optum partnership aims to make trial timelines and costs more predictable. Credit: Stock.Adobe.com/wladimir1804

October 20th, 2026

Syneos Health, Optum Partner on Adaptive Clinical Development Model

Syneos Health and Optum outline a joint model for trial planning, recruitment and site access, with no financial terms or timelines disclosed.

Deidentified real-world data, project-by-project review and an Abu Dhabi hypertension program anchor an early-stage AstraZeneca-Oracle AI collaboration. Credit: Stock.Adobe.com/Konstantin Yuganov

October 20th, 2026

AstraZeneca and Oracle Outline AI Collaboration for Clinical Trial Recruitment and Safety Monitoring

What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance.

October 20th, 2026

Where AI Governance in Clinical Development Falls Short

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, identifies three recurring failure modes in AI governance frameworks—and explains why responsible AI must be an ongoing operating discipline, not a one-time approval gate.